Application for quotation of securities - PER

Sep 6, 2026 at 6:25 PM EDT · Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · Sep 6, 2026 at 6:25 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-per-2

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 5Announcement SummaryEntity namePERCHERON THERAPEUTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementMonday September 07, 2026The +securities to be quoted are:Total...

View Attachment

6ix hasn’t read this filing yet.

Percheron Therapeutics Limited on 6ix

Earlier from Percheron Therapeutics

2026 Notice of Annual General MeetingSep 6
Percheron Therapeutics Limited Corporate PresentationAug 31
Percheron raises $2.3m to fully fund clinical trial in AMLAug 31
Proposed issue of securities - PERAug 31
Initial Director's Interest NoticeAug 31

Later from Percheron Therapeutics

Notice under S708ASep 7
Dr Michael Baker Commences as CEO and MDOct 4
Final Director's Interest NoticeOct 4
Annual General Meeting - Chair AddressOct 6
Annual General Meeting - Management PresentationOct 6

All Percheron Therapeutics news releases

Follow Percheron Therapeutics into a list and get an email when it puts out news.

Follow Percheron Therapeutics